Sophie Miriam Lanzkron, M.D., M.H.S.

Dr. Lanzkron's major clinical research involves the study of sickle cell disease. Her primary research interest is to understand the barriers to care for adults with sickle cell disease. She has done pivotal work on barriers to the use of hydroxyurea to treat people with sickle cell disease. Her research has also focused on the benefits of the use of infusion clinics for the management of uncomplicated painful episodes culminating in a multisite study demonstrating improved patient centered outcomes when comparing infusion clinics to  emergency departments in managing such episodes.  Research is ongoing to implement the infusion clinic model across the US.